Intravenous stem cell infusion therapy involves the administration of autologous, concentrated cell-derived components via the venous system. These cells circulate throughout the body and selectively migrate to damaged tissues through a tissue-specific homing mechanism, followed by engraftment within the local microenvironment, where they promote anti-inflammatory effects and tissue regeneration.
This approach may aid in the recovery of chronic inflammatory conditions, support cellular function, modulate immune responses, and enhance overall vitality.